Search results
Revolution Crashes 34% On A Flop In Pancreatic Cancer Treatment. But There's A Silver Lining.
Investor's Business Daily· 8 months agoBiotech stock Revolution Medicines collapsed Monday after unveiling test results for an experimental...
Kura Makes Good On Its $150 Million Infusion And Shoots Up 12%
Investor's Business Daily· 4 months agoKura stock surged to a nearly three-year high Tuesday after Kura Oncology unveiled promising test...
Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish
Investor's Business Daily· 2 months agoNovocure stock surged to its 50-day line on Wednesday after the company's medtech device nearly...
Q4 2023 MacroGenics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Jim Karrels; SVP, CFO & Secretary; MacroGenics, Inc. Scott Koenig; President, CEO & Director; MacroGenics, Inc. Jonathan Chang; Analyst; Leerink Partners LLC Kelsey Goodwin; Analyst ...
Q4 2023 Mersana Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Jason Fredette; SVP, IR and Corporate Communications; Mersana Therapeutics Inc Marty Huber; President and CEO; Mersana Therapeutics Inc Brian DeSchuytner; SVP, COO and CFO; Mersana ...
Q4 2023 Kura Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Pete De Spain; Executive Vice President of Investor Relations & Corporate Communications; Kura Oncology Inc Troy Wilson; President, CEO, Board Member; Kura Oncology Inc Tom Doyle ...
Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'
Investor's Business Daily· 5 months agoCancer-focused biotech companies Ambrx and Harpoon Therapeutics snapped up a pair of takeover deals...
Q4 2023 Revolution Medicines Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Erin Graves; Head of Corporate Communications and Investor Relations; Revolution Medicines Inc Mark Goldsmith; President, CEO, Chairman; Revolution Medicines Inc Jack Anders; Chief ...
Why Revolution Medicines Stock Is Crashing Today
Motley Fool· 8 months agoShares of Revolution Medicines (NASDAQ: RVMD) were crashing 42.5% lower as of 11:13 a.m. ET on Monday. The steep decline came after the oncology company...
